308 related articles for article (PubMed ID: 9199064)
1. [COX-2 inhibition: latest on NSAID].
Z Orthop Ihre Grenzgeb; 1997; 135(1):Oa20-1. PubMed ID: 9199064
[No Abstract] [Full Text] [Related]
2. Coming: a review of second-generation nonsteroidal anti-inflammatory drugs.
Housholder GT; Chan JT
J Gt Houst Dent Soc; 1997 Mar; 68(8):13-6. PubMed ID: 9594801
[No Abstract] [Full Text] [Related]
3. Effect of structural modification of enol-carboxamide-type nonsteroidal antiinflammatory drugs on COX-2/COX-1 selectivity.
Lazer ES; Miao CK; Cywin CL; Sorcek R; Wong HC; Meng Z; Potocki I; Hoermann M; Snow RJ; Tschantz MA; Kelly TA; McNeil DW; Coutts SJ; Churchill L; Graham AG; David E; Grob PM; Engel W; Meier H; Trummlitz G
J Med Chem; 1997 Mar; 40(6):980-9. PubMed ID: 9083488
[TBL] [Abstract][Full Text] [Related]
4. [COX-1 and COX-2: functions and pharmacological effects].
Hinz B; Brune K
Pharm Unserer Zeit; 1999 Jan; 28(1):21-9. PubMed ID: 10078026
[No Abstract] [Full Text] [Related]
5. Thiazole analogues of the NSAID indomethacin as selective COX-2 inhibitors.
Woods KW; McCroskey RW; Michaelides MR; Wada CK; Hulkower KI; Bell RL
Bioorg Med Chem Lett; 2001 May; 11(10):1325-8. PubMed ID: 11392547
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of pharmacological profile of meloxicam as an anti-inflammatory agent, with particular reference to its relative selectivity for cyclooxygenase-2 over cyclooxygenase-1.
Ogino K; Hatanaka K; Kawamura M; Katori M; Harada Y
Pharmacology; 1997 Jul; 55(1):44-53. PubMed ID: 9309800
[TBL] [Abstract][Full Text] [Related]
7. [Therapy with preferential and specific COX-2 inhibitors].
Stichtenoth DO; Frölich JC
Internist (Berl); 2001 Mar; 42(3):421-6. PubMed ID: 11277028
[No Abstract] [Full Text] [Related]
8. Cox-2-selective inhibitors: the new super aspirins.
DeWitt DL
Mol Pharmacol; 1999 Apr; 55(4):625-31. PubMed ID: 10101019
[No Abstract] [Full Text] [Related]
9. The future of NSAID therapy: selective COX-2 inhibitors.
Vane JR; Botting RM
Int J Clin Pract; 2000; 54(1):7-9. PubMed ID: 10750251
[No Abstract] [Full Text] [Related]
10. Meloxicam inhibits prostaglandin E(2) generation via cyclooxygenase 2 in the inflammatory site but not that via cyclooxygenase 1 in the stomach.
Ogino K; Hatanaka K; Kawamura M; Ohno T; Harada Y
Pharmacology; 2000 Nov; 61(4):244-50. PubMed ID: 11093076
[TBL] [Abstract][Full Text] [Related]
11. [A heterogenous drug class. NSAID: classification and spectrum of action].
Ulbrich H; Dannhardt G
Pharm Unserer Zeit; 2002; 31(2):146-54. PubMed ID: 11977450
[No Abstract] [Full Text] [Related]
12. COX-2 inhibitors--is there cause for concern?
Seibert K; Lefkowith J; Tripp C; Isakson P; Needleman P
Nat Med; 1999 Jun; 5(6):621-2. PubMed ID: 10371498
[No Abstract] [Full Text] [Related]
13. COX-1 and COX-2 inhibition: current status and future perspective.
Greyn J; Lauwers MH; Vanlersberghe C; Camu F
Acta Anaesthesiol Belg; 1998; 49(3):175-83. PubMed ID: 9844704
[No Abstract] [Full Text] [Related]
14. The discovery and function of COX-2.
Needleman P; Isakson PC
J Rheumatol Suppl; 1997 Jul; 49():6-8. PubMed ID: 9249644
[No Abstract] [Full Text] [Related]
15. [How do aspirin and company work? Cyclooxygenases--point of attack of nonsteroidal antirheumatics].
Steinhilber D
Pharm Unserer Zeit; 2002; 31(2):140-4. PubMed ID: 11977449
[No Abstract] [Full Text] [Related]
16. Flurbiprofen and enantiomers in ophthalmic solution tested as inhibitors of prostanoid synthesis in human blood.
van Haeringen NJ; van Sorge AA; Van Delft JL; Carballosa Coré-Bodelier VM
J Ocul Pharmacol Ther; 2000 Aug; 16(4):345-52. PubMed ID: 10977130
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of action of anti-inflammatory drugs.
Vane JR; Botting RM
Adv Exp Med Biol; 1997; 433():131-8. PubMed ID: 9561120
[No Abstract] [Full Text] [Related]
18. In vitro effects of selective and non-selective nonsteroidal anti-inflammatory drugs on the frequency of sister chromatid exchanges.
Oztürk S; Köseoglu BG; Koçak H; Palanduz S; Cefle K; Erkal H
Drugs R D; 2004; 5(6):327-30. PubMed ID: 15563235
[No Abstract] [Full Text] [Related]
19. [Cyclooxygenases, structure, biological functions and the role in inflammation processes].
Kotyla PJ; Sliwińska-Kotyla B; Kucharz EJ
Pol Arch Med Wewn; 2001 Oct; 106(4):963-6. PubMed ID: 11993417
[No Abstract] [Full Text] [Related]
20. Closing in on a stomach-sparing aspirin substitute.
Service RF
Science; 1996 Sep; 273(5282):1660. PubMed ID: 8830410
[No Abstract] [Full Text] [Related]
[Next] [New Search]